The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved vaccine considered among the best in its class.
23 November 2023
The University of Queensland’s small molecule drug discovery facility will open its doors to researchers from across Australia for the first time thanks to a National Collaborative Research Infrastructure Strategy (NCRIS) funding injection.
31 October 2023
Queensland will become a major international hub for vaccine discovery and development with a global partnership formed in the United States today to help address the world’s critical health challenges.
7 June 2023
A University of Queensland-led research effort to develop an mRNA vaccine against Group A Streptococcus (Strep A) has secured almost $8 million in philanthropic funding.
14 February 2023
University of Queensland researchers have developed a world-first surface spray that has the potential to kill viruses such as COVID-19 and potentially deadly bacteria.
18 January 2023
A University of Queensland team has become the biggest supplier of experimental mRNA vaccines and therapies in Australia, with burgeoning demand from research and industry across the country.
11 January 2023
